Jenburkt Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE354A01013
NSEID:
BSEID: 524731

INR

1,105.70

0.00 (0.00%)

BSENSE

Dec 04

BSE+NSE Vol: 2.34 k

{
  "main_header": {
    "sid": 134395,
    "name": "Jenburkt Pharma",
    "stock_name": "Jenburkt Pharma",
    "full_name": "Jenburkt Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/jenburkt-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,105.70",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "1,105.70",
    "mcapval": "498.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524731,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE354A01013",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "2.34 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jenburkt-pharma-134395-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Jenburkt Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jenburkt-pharma-fallingrising-3747164",
        "imagepath": "",
        "date": "2025-12-05 00:43:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Performance and Market Comparison</strong></p>\n<p>Jenburkt Pharma’s recent price trajectory has been disappointing when compared to the broader market. Over the past week, the stock has declined by 5.64%, significantly underperforming the Sensex, which fell by only 0.53% during the same period. The one-month performance paints an even starker picture, with the stock dropping 12.40% while the Sensex gained 2.16%. Year-to-date, Jenburkt Pharma’s shares are down 8.97%, contrasting sharply with the Sensex’s 9.12% rise. This divergence highlights the stock’s vulnerability amid a generally positive market environment.</p>\n<p>Despite these short-term setbacks, the company’s longer-term returns remain robust. Over three years, Jenburkt Pharma has delivered a 76.74% gain, more than d..."
      },
      {
        "title": "Is Jenburkt Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jenburkt-pharma-technically-bullish-or-bearish-3739982",
        "imagepath": "",
        "date": "2025-12-02 08:23:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Price Action and Trend</strong></p>\n<p>As of the latest trading session, Jenburkt Pharma closed at ₹1,146.65, down from the previous close of ₹1,167.75. The stock's intraday range fluctuated between ₹1,140.00 and ₹1,185.00, reflecting moderate volatility. Over the past 52 weeks, the share price has oscillated between a low of ₹936.70 and a high of ₹1,410.00, indicating a wide trading band and significant price movement over the year.</p>\n<p>The technical trend recently transitioned from a sideways pattern to mildly bearish on 1 December 2025, signalling a subtle shift in market sentiment. This change suggests that the stock may be facing increased selling pressure or a lack of strong buying interest in the near term.</p>\n<p><strong>Technical Indicators: Mixed Signals Acro..."
      },
      {
        "title": "Jenburkt Pharmaceuticals: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-sees-mixed-technical-signals-amid-mild-bearish-momentum-3739883",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JenburktPharmac_technicaldot_3739883.png",
        "date": "2025-12-02 08:00:54",
        "description": "Jenburkt Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a sideways trend to a mildly bearish stance, underscoring the evolving market dynamics for this Pharmaceuticals & Biotechnology sector stock."
      },
      {
        "title": "Jenburkt Pharma Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharma-upgraded-from-sell-to-hold-by-marketsmojo-on-29-oct-2025-3738149",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JenburktPharma_mojoScore_3738149.png",
        "date": "2025-12-01 10:09:02",
        "description": "Jenburkt Pharma's market evaluation has undergone a notable revision, reflecting a shift in analytical perspective driven by recent financial and technical developments. The pharmaceutical microcap's assessment now indicates a more balanced outlook, influenced by its operational performance and valuation considerations within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Jenburkt Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jenburkt-pharma-technically-bullish-or-bearish-3716841",
        "imagepath": "",
        "date": "2025-11-20 08:10:12",
        "description": "As of 19 November 2025, the technical trend for Jenburkt Pharma has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing this position. The weekly MACD remains bullish, while the monthly MACD is mildly bearish, indicating a divergence in momentum. The Bollinger Bands show a bullish signal on the weekly chart but are mildly bullish on the monthly chart. The daily moving averages are mildly bearish, suggesting short-term weakness. The KST is mildly bullish on the weekly but mildly bearish on the monthly, adding to the mixed signals. Overall, the lack of definitive trends in both the Dow Theory and RSI further supports a neutral outlook...."
      },
      {
        "title": "Jenburkt Pharmaceuticals: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-technical-momentum-shifts-amid-mixed-market-signals-3717067",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JenburktPharmac_technicaldot_3717067.png",
        "date": "2025-11-20 08:00:27",
        "description": "Jenburkt Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a mildly bullish trend to a sideways movement, underscoring the need for investors to carefully analyse the evolving technical indicators and price action within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Jenburkt Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jenburkt-pharma-technically-bullish-or-bearish-3713783",
        "imagepath": "",
        "date": "2025-11-19 08:13:17",
        "description": "As of 18 November 2025, the technical trend for Jenburkt Pharma has changed from sideways to mildly bullish. The weekly MACD is bullish, supporting the positive sentiment, while the monthly MACD also confirms this bullish stance. Bollinger Bands indicate a bullish trend on the weekly and a mildly bullish trend on the monthly. However, daily moving averages show a mildly bearish position, which introduces some caution. The KST is mildly bullish on the weekly but mildly bearish on the monthly, indicating mixed signals. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and Bollinger Bands on the weekly timeframe...."
      },
      {
        "title": "Jenburkt Pharmaceuticals Technical Momentum Shifts Signal Market Attention",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-technical-momentum-shifts-to-mildly-bullish-amid-market-volatility-3714089",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JenburktPharmac_technicaldot_3714089.png",
        "date": "2025-11-19 08:00:35",
        "description": "Jenburkt Pharmaceuticals . has exhibited a notable shift in its technical parameters, signalling a change in price momentum that investors and market analysts are closely monitoring. The stock’s recent movement from a sideways trend to a mildly bullish stance is supported by a combination of technical indicators, reflecting evolving market sentiment within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jenburkt Pharmaceuticals Shows Mixed Technical Trends Amidst Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-technical-trend-shifts-from-mildly-bearish-to-sideways-amid-stock-price-increase-3709598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JenburktPharmac_technicaldot_3709598.png",
        "date": "2025-11-18 08:00:32",
        "description": "Jenburkt Pharmaceuticals, a microcap in the Pharmaceuticals & Biotechnology sector, has recently revised its evaluation amid changing market conditions. The stock has shown a modest annual return of 2.98%, significantly lower than the Sensex's 9.50%. Despite recent fluctuations, the company has demonstrated strong long-term growth, outperforming the Sensex over five years."
      }
    ],
    "total": 480,
    "sid": "134395",
    "stock_news_url": "https://www.marketsmojo.com/news/jenburkt-pharmaceuticals-134395"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-Oct-2025",
      "details": "Newspaper Publication for Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 28Th October 2025.",
      "datetime": "28-Oct-2025",
      "details": "Outcome of the Board Meeting held today on 28th October 2025.",
      "source": "BSE"
    },
    {
      "caption": "Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2025.",
      "datetime": "28-Oct-2025",
      "details": "Standalone Unaudited financial results for the quarter and half year ended on 30th September 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jenburkt Pharmaceuticals Ltd. has declared <strong>180%</strong> dividend, ex-date: 11 Jul 25",
          "dt": "2025-07-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Jenburkt Pharma falling/rising?

2025-12-05 00:43:33

Short-Term Price Performance and Market Comparison

Jenburkt Pharma’s recent price trajectory has been disappointing when compared to the broader market. Over the past week, the stock has declined by 5.64%, significantly underperforming the Sensex, which fell by only 0.53% during the same period. The one-month performance paints an even starker picture, with the stock dropping 12.40% while the Sensex gained 2.16%. Year-to-date, Jenburkt Pharma’s shares are down 8.97%, contrasting sharply with the Sensex’s 9.12% rise. This divergence highlights the stock’s vulnerability amid a generally positive market environment.

Despite these short-term setbacks, the company’s longer-term returns remain robust. Over three years, Jenburkt Pharma has delivered a 76.74% gain, more than d...

Is Jenburkt Pharma technically bullish or bearish?

2025-12-02 08:23:37

Overview of Current Price Action and Trend

As of the latest trading session, Jenburkt Pharma closed at ₹1,146.65, down from the previous close of ₹1,167.75. The stock's intraday range fluctuated between ₹1,140.00 and ₹1,185.00, reflecting moderate volatility. Over the past 52 weeks, the share price has oscillated between a low of ₹936.70 and a high of ₹1,410.00, indicating a wide trading band and significant price movement over the year.

The technical trend recently transitioned from a sideways pattern to mildly bearish on 1 December 2025, signalling a subtle shift in market sentiment. This change suggests that the stock may be facing increased selling pressure or a lack of strong buying interest in the near term.

Technical Indicators: Mixed Signals Acro...

Read More

Jenburkt Pharmaceuticals: Technical Momentum Shifts Amid Mixed Market Signals
2025-12-02 08:00:54
Jenburkt Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a sideways trend to a mildly bearish stance, underscoring the evolving market dynamics for this Pharmaceuticals & Biotechnology sector stock.
Read More

Jenburkt Pharma Sees Revision in Market Evaluation Amid Mixed Financial Signals
2025-12-01 10:09:02
Jenburkt Pharma's market evaluation has undergone a notable revision, reflecting a shift in analytical perspective driven by recent financial and technical developments. The pharmaceutical microcap's assessment now indicates a more balanced outlook, influenced by its operational performance and valuation considerations within the Pharmaceuticals & Biotechnology sector.
Read More

Is Jenburkt Pharma technically bullish or bearish?
2025-11-20 08:10:12
As of 19 November 2025, the technical trend for Jenburkt Pharma has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing this position. The weekly MACD remains bullish, while the monthly MACD is mildly bearish, indicating a divergence in momentum. The Bollinger Bands show a bullish signal on the weekly chart but are mildly bullish on the monthly chart. The daily moving averages are mildly bearish, suggesting short-term weakness. The KST is mildly bullish on the weekly but mildly bearish on the monthly, adding to the mixed signals. Overall, the lack of definitive trends in both the Dow Theory and RSI further supports a neutral outlook....
Read More

Jenburkt Pharmaceuticals: Technical Momentum Shifts Amid Mixed Market Signals
2025-11-20 08:00:27
Jenburkt Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a mildly bullish trend to a sideways movement, underscoring the need for investors to carefully analyse the evolving technical indicators and price action within the Pharmaceuticals & Biotechnology sector.
Read More

Is Jenburkt Pharma technically bullish or bearish?
2025-11-19 08:13:17
As of 18 November 2025, the technical trend for Jenburkt Pharma has changed from sideways to mildly bullish. The weekly MACD is bullish, supporting the positive sentiment, while the monthly MACD also confirms this bullish stance. Bollinger Bands indicate a bullish trend on the weekly and a mildly bullish trend on the monthly. However, daily moving averages show a mildly bearish position, which introduces some caution. The KST is mildly bullish on the weekly but mildly bearish on the monthly, indicating mixed signals. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and Bollinger Bands on the weekly timeframe....
Read More

Jenburkt Pharmaceuticals Technical Momentum Shifts Signal Market Attention
2025-11-19 08:00:35
Jenburkt Pharmaceuticals . has exhibited a notable shift in its technical parameters, signalling a change in price momentum that investors and market analysts are closely monitoring. The stock’s recent movement from a sideways trend to a mildly bullish stance is supported by a combination of technical indicators, reflecting evolving market sentiment within the Pharmaceuticals & Biotechnology sector.
Read More

Jenburkt Pharmaceuticals Shows Mixed Technical Trends Amidst Market Evaluation Revision
2025-11-18 08:00:32
Jenburkt Pharmaceuticals, a microcap in the Pharmaceuticals & Biotechnology sector, has recently revised its evaluation amid changing market conditions. The stock has shown a modest annual return of 2.98%, significantly lower than the Sensex's 9.50%. Despite recent fluctuations, the company has demonstrated strong long-term growth, outperforming the Sensex over five years.
Read More